The underlying mechanism may involve the LPS-induced activation of NF-κB and an increase in both connexin 43 expression and lateral distribution through the α1-adrenergic receptor-dependent pathway that promotes AF inducibility in LPS-induced systemic inflammation [90]. The gene discussed is NFKB1; the disease is atrial fibrillation.